Use of polycyclic aromatic compounds for making medicines capable of inhibiting telomerase
申请人:——
公开号:US20040034023A1
公开(公告)日:2004-02-19
The invention concerns the use of aromatic compounds capable of binding with G-quadruplex structures to produce medicines with anti-telomerase effect. Said compounds correspond to formula (I) wherein: R
1
, R
2
and R
3
, identical or different, represent a hydrogen atom, or a —CH
2
—NH—(CH
2
)
n
—X group, wherein n is an integer from 2 to 4, and X is selected among —NH
2
—, —N(CH
3
)
2
radicals, a heterocyclic radical such as piperidyl, imidazolyl, morpholinyl radical, or an indole-type condensed heterocyclic radical, —Z represents CH or N, each compound comprising two nitrogen atoms in the Z positions. The invention is useful for producing anticancer medicines.
本发明涉及使用具有与G四链结构结合能力的芳香化合物来制备具有抗端粒酶效应的药物。所述化合物对应于式(I),其中:R1、R2和R3相同或不同,表示氢原子或—CH2—NH—(CH2)n—X基团,其中n是2至4的整数,X选自—NH2—、—N(CH3)2基团、如哌啶基、咪唑基、吗啉基或吲哚型缩合杂环基团等杂环基团;—Z表示CH或N,每种化合物在Z位置含有两个氮原子。本发明有助于制备抗癌药物。